Low-dose cyclophosphamide combined with chinese herbal medicine Shuli Fenxiao formula for the treatment of intermediate-to-high risk primary membranous nephropathy.

Front Immunol · 2025 · PMC12053483 · PMID 40330486

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Although the Scr showed a decreasing trend and the estimated glomerular filtration rate both increased after treatment compared to before, the difference between before and after treatment was not statistically significant in both cases ( P > 0.05). 3.3.3.

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.